Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 10/9/2019 5:37:59 PM - Followers: 72 - Board type: Free - Posts Today: 0
ENTA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA News: Enanta Pharmaceuticals to Present at the 2019 Wolfe Research Healthcare Conference 10/21/2019 04:00:00 PM
ENTA News: Statement of Changes in Beneficial Ownership (4) 10/09/2019 05:18:42 PM
ENTA News: New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV Demonstrates Highly Statistically Significant Redu... 10/03/2019 07:30:00 AM
ENTA News: Statement of Changes in Beneficial Ownership (4) 09/30/2019 04:46:08 PM
ENTA News: Statement of Ownership (sc 13g) 09/27/2019 04:26:10 PM
PostSubject
#1817  Sticky Note Musings on ENTA’s buyout vig: #msg-151399889. DewDiligence 09/27/19 02:51:31 PM
#1820   Yet another: #msg-151617214. DewDiligence 10/09/19 05:37:59 PM
#1819   EDP-938 ancillary phase-2a data presented at IDWeek: DewDiligence 10/03/19 08:27:53 AM
#1818   Another bullish insider transaction: #msg-151441695. DewDiligence 09/30/19 05:04:54 PM
#1817   Musings on ENTA’s buyout vig: #msg-151399889. DewDiligence 09/27/19 02:51:31 PM
#1816   Deja vu? willyw 09/27/19 01:21:23 PM
#1815   FDA shortens approved Mavyret regimen for treatment-naïve cirrhotics DewDiligence 09/27/19 09:12:28 AM
#1814   FDA shortens approved Mavyret regimen for treatment-naïve cirrhotics DewDiligence 09/27/19 02:03:28 AM
#1813   Many thanks! I always appreciate your informed and willyw 09/26/19 10:13:43 PM
#1812   This isn’t a yes/no binary matter—it’s a question DewDiligence 09/26/19 08:51:55 PM
#1811   "It might be a mistake to interpret Luly’s willyw 09/26/19 07:16:21 PM
#1810   I'm certainly not as up to speed as willyw 09/26/19 05:47:55 PM
#1809   You make some good points. However, I’m not DewDiligence 09/26/19 05:07:00 PM
#1808   Oh, I'm in agreement that Viekira wasn't a willyw 09/26/19 04:31:18 PM
#1807   I harken back to Viekira. What if ENTA DewDiligence 09/26/19 03:08:38 PM
#1806   Thx. I must be confusing some recently semi_infinite 09/26/19 02:56:24 PM
#1805   …given so-so results in RSV and HBV (if DewDiligence 09/26/19 02:50:07 PM
#1804   Besides that FXR prospect, do you ascribe any semi_infinite 09/26/19 02:09:21 PM
#1803   Several points I'd make; willyw 09/26/19 12:12:16 PM
#1802   Do you see any value [for the DewDiligence 09/26/19 09:58:09 AM
#1801   Too bad about the itching at 2.5mg. semi_infinite 09/26/19 09:49:32 AM
#1800   ENTA reports phase-2a NASH data for EDP-305: #msg-151356515. DewDiligence 09/25/19 04:17:36 PM
#1799   EDP-938 oral presentation at IDWeek* on 10/3/19: DewDiligence 09/10/19 07:52:02 AM
#1798   New slide set (for today’s Baird webcast): DewDiligence 09/04/19 01:24:21 PM
#1797   USPSTF recommends HCV screening for essentially all US adults: DewDiligence 08/28/19 11:47:10 AM
#1796   ENTA FY3Q19 CC transcript: DewDiligence 08/07/19 09:10:52 AM
#1795   ENTA latest slide set (7/11/19): DewDiligence 08/06/19 04:32:40 PM
#1794   ENTA FY3Q19 results: DewDiligence 08/06/19 04:07:21 PM
#1793   EDP-305 cannot logically be worse than OCA on DewDiligence 08/05/19 01:27:58 PM
#1792   thx. If recollection serves, OCA complications were semi_infinite 08/05/19 01:22:59 PM
#1791   FYI: #msg-150331278. DewDiligence 08/05/19 11:55:15 AM
#1790   I would agree on the granular level. semi_infinite 08/02/19 11:49:12 AM
#1789   (Dew Wrote) Moreover, the patient pool in question willyw 08/02/19 11:38:28 AM
#1788   Option pricing was prescient in the way DewDiligence 08/02/19 11:25:27 AM
#1787   How does the newly EMA approved shorter treatment DewDiligence 08/02/19 11:10:54 AM
#1786   Option pricing was prescient in the way the semi_infinite 08/02/19 10:34:33 AM
#1785   Enanta’s HCV Collaboration Partner AbbVie receives Approval by willyw 08/02/19 08:58:45 AM
#1784   At current stock price, options no longer skewed semi_infinite 07/26/19 10:19:21 AM
#1783   ABBV’s 2Q19 HCV sales=$784M—2019 guidance lowered $3.3B—>$3.1B: DewDiligence 07/26/19 09:26:43 AM
#1781   I reposted with full URLs. DewDiligence 07/14/19 06:34:41 PM
#1780   I couldn't open it. Give me the 5 cent Glider549 07/14/19 06:31:11 PM
#1779   Here's a capsule summary of the trial: DewDiligence 07/14/19 06:28:52 PM
#1778   EDP 305 Argon 1 Phase 2 initial Dara Glider549 07/14/19 06:24:49 PM
#1777   ENTA starts phase-1 of EDP-514 for treatment of HBV: DewDiligence 07/08/19 10:04:28 AM
#1776   ENTA’s General Counsel exercised and held ~$270K of DewDiligence 06/26/19 06:41:53 PM
#1775   On today’s CC, ABBV reiterated its guidance for DewDiligence 06/25/19 06:01:44 PM
#1774   ABBV's Mavyret weekly NRx market share of the guyschmid 06/21/19 10:26:59 AM
#1773   New corporate slide set: DewDiligence 06/19/19 11:33:49 AM
#1772   JNJ’s failure in RSV has no bearing on DewDiligence 06/16/19 07:15:26 PM
#1771   Musings on the EDP-938 data: #msg-149396106. DewDiligence 06/14/19 09:34:03 PM
#1770   ENTA reports EDP-938 phase-2 data… DewDiligence 06/14/19 10:49:26 AM
PostSubject